For HCPs: Viewpoints on CheckMate-9ER and a case study
Автор: CABOMETYX® (cabozantinib)
Загружено: 2026-01-20
Просмотров: 7
Please see Full Prescribing Information for CABOMETYX (cabozantinib): https://www.cabometyxhcp.com/prescrib...
This video is intended for US healthcare professionals only.
Dr. Katy Beckermann and Dr. Elizabeth Wulff discuss the primary analysis and 5-year minimal follow-up data for CABOMETYX + OPDIVO (nivolumab) from the CHECKMATE-9ER clinical trial.
Product information provided in these videos is intended only for US healthcare professionals. These videos are sponsored by Exelixis, Inc, and were developed in conjunction with Dr. Beckermann and Dr. Wulff. Dr. Beckermann and Dr. Wulff received a fee for participating in these videos. Their comments reflect their opinions and are not intended to constitute medical advice for individual patients. The case study details presented are hypothetical. Individual results may vary.
Доступные форматы для скачивания:
Скачать видео mp4
-
Информация по загрузке:
